Plus   Neg

Nvidia Q2 Profit Rises, Strong Outlook

Nvidia Corp. (NVDA) on Wednesday reported a second-quarter profit and revenues that trumped Wall Street estimates, as data center business generated more revenues than the company's key gaming business. Looking forward, the company expects its third-quarter revenues to beat current expectations.

Santa Clara, California-based Nvidia's second-quarter profit rose to $622 million or $0.99 per share from $552 million or $0.90 per share last year.

Adjusted earnings were $2.18 per share, up from $1.24 per share in the year ago period. On average, 30 analysts polled by Thomson Reuters estimated earnings of $1.97 per share for the quarter.

Nvidia's revenues for the quarter surged 50% to $3.87 billion from $2.58 billion in the year-ago quarter. Analysts had a consensus revenue estimate of $3.65 billion for the quarter.

"Adoption of NVIDIA computing is accelerating, driving record revenue and exceptional growth," said Jensen Huang, founder and CEO of NVIDIA. "Growth in GeForce gaming accelerated as gamers increasingly immerse themselves in realistic virtual worlds created by NVIDIA RTX ray tracing and AI.

Revenue from gaming, Nvidia's core business, gained 24% to $1.65 billion, however, data-center business generated more revenues than key gaming business, as it surged 54% to $1.75 billion.

Looking forward to the third quarter, the company expects revenues of $4.40 billion, plus or minus two percent. Analysts currently estimate revenues of $3.97 billion for the quarter.

NVDA closed Thursday's trading at $148.77, down $1.30 or 0.87%, on the Nasdaq. The stock, however, gained $9.41 or 6.33% in the after-hours trade.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Santa Cruz Bicycles LLC has recalled certain model year 2020 bicycles with aluminum frames citing fall risks, according to the U.S. Consumer Product Safety Commission. The recall involves about 2,900 units of model year 2020 Auminum Santa Cruz and Juliana Bicycles. In addition, about 216 were sold in Canada. AstraZeneca is mulling an additional global trial to confirm the 90% efficacy rate of its Covid-19 vaccine candidate at lower dosage, Bloomberg news quoted Chief Executive Officer Pascal Soriot as saying. In an interview, Soriot noted that instead of adding the trial to an ongoing U.S. process, the company might launch a fresh study to evaluate efficacy of lower dosage of its vaccine that perform U.S. airline Delta Air Lines, Inc. and its Italian codeshare partner Alitalia are planning to launch quarantine-free, COVID-free flights between U.S. and Europe through new testing protocols, starting in December. In a statement, Delta said it has signed deals with airports and governments eliminating quarantine requirements on COVID-tested flights connecting Atlanta and Rome.
Follow RTT